Smart Melphalan Formulation Management System
Legal Citation
Summary of the Inventive Concept
A comprehensive system integrating melphalan injectable formulations with cutting-edge technologies like AI, IoT, blockchain, and wearables to ensure stability, optimize storage, and personalize treatment.
Background and Problem Solved
The original patent addressed the need for stable and ready-to-use injectable formulations of melphalan. However, the existing solutions lack real-time monitoring, automated optimization, and personalized treatment. This inventive concept tackles these limitations by incorporating synergistic technologies to create a more powerful system.
Detailed Description of the Inventive Concept
The Smart Melphalan Formulation Management System consists of multiple components: (1) a sensor-enabled injectable formulation that detects degradation and alerts users; (2) an AI-driven processor that analyzes environmental data and predicts optimal storage conditions; (3) a blockchain-based ledger for tracking and verifying authenticity and integrity; (4) a wearable device for monitoring treatment efficacy; and (5) an AI-powered dosing regimen predictor. These components interact seamlessly to ensure the stability, efficacy, and personalization of melphalan injectable formulations.
Novelty and Inventive Step
The inventive concept's novelty lies in the synergistic integration of distinct technologies to create a comprehensive system that addresses the limitations of existing melphalan formulations. The inventive step is the combination of these technologies to provide real-time monitoring, automated optimization, and personalized treatment, which is not obvious from the original patent.
Alternative Embodiments and Variations
Alternative embodiments may include using different types of sensors, AI algorithms, or blockchain platforms. Variations could involve integrating the system with electronic health records or using machine learning to predict patient responses to different dosing regimens.
Potential Commercial Applications and Market
The Smart Melphalan Formulation Management System has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of cancer treatment, personalized medicine, and supply chain management.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/08 |
| A | A61 | A61K9/0019 |
| A | A61 | A61K31/198 |
| A | A61 | A61K47/10 |
| A | A61 | A61K47/183 |
| A | A61 | A61K47/32 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical formulation engineering, specifically injectable drug delivery systems with a focus on stability, monitoring, and personalized medicine technologies
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmaceutical sciences, chemical engineering, or biomedical engineering, having expertise in drug formulation, sensor technologies, data analytics, and medical device integration
Obviousness Rationale
A PHOSITA would recognize that integrating sensor, AI, and blockchain technologies into pharmaceutical formulation management represents a predictable extension of existing stability and tracking approaches. The core technical problem of melphalan formulation stability is directly addressed through advanced monitoring technologies that are well-established in adjacent technical domains. The proposed system combines known technologies in a manner that would be considered routine optimization for a skilled practitioner seeking enhanced pharmaceutical product management.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,677 |
|---|---|
| Title | Ready to use injectable formulations of melphalan and processes for preparation thereof |
| Assignee(s) | RK PHARMA INC. |